Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Date:

October 16, 2024

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.

Source link

Amazon, Google make dueling nuclear investments to power data centers with clean energy

Leeds duo Daniel James and Manor Solomon return from injury absences

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Recent posts

Why Saudi Arabia may ‘open the spigot’ on oil production — and crater crude prices

Dollar General asks shareholders to reject investment firm’s stock-purchase offer

Monster Beverages’ stock is sinking. Executives are blaming convenience stores.

Victoria’s Secret says it won these ‘major moments’ as it bumps full-year sales forecast

Oil prices higher after cooler U.S. inflation data

Earnings Watch: More retailers, CrowdStrike, Nvidia — and the ‘most important tech earnings in years?’

Oil prices slip as geopolitical worries ebb

Cava’s stock slides 8% after CEO and other insiders announce stock sales

Biden needs to push through promised student-loan relief before Trump returns to White House, powerful Democrat warns

Meta and Amazon donations of $1 million to Trump’s inauguration follow a history of companies cozying up to incoming presidents

Oil prices on track for weekly gains as Middle East worries linger

Oil may ‘collapse’ below $50 a barrel in 2025 if this perfect storm hits the market

Why solar is the fastest-growing source of U.S. electricity

Gold posts record-high finish, lifted by Fed rate-cut hopes, Middle East violence

Trump proposes that U.S. government or insurers cover all costs for IVF

Related articles

Cocoa’s the best-performing commodity in 2024 — and even beat bitcoin. What’s next.

As the wealthy keep spending, here’s why the middle class is in for a tough 2025

How this Treasury-market dynamic could lead to the next big leg lower in stocks

As Teamsters go on strike, Amazon and its investors are trying to shrug it off

Oil may ‘collapse’ below $50 a barrel in 2025 if this perfect storm hits the market

New investigation rips Amazon’s safety record. That’s not slowing the tech giant’s stock.

U.S. oil prices drop nearly 1% on weak Chinese retail-sales data

UnitedHealth Group CEO says healthcare needs fixing. Start with these 3 problems in claims and patient costs, experts say.

Company

Follow us